New Zealand Prime Minister Jacinda Ardern receiving her first Pfizer/BioNTech dose, June 18 (Alex Burton/NZ Herald via AP Images)

Covid-19 roundup: Af­ter win­ning an EUA, GSK and Vir are back with full da­ta on their mon­o­clon­al an­ti­body; New Zealand au­tho­rizes Pfiz­er/BioN­Tech vac­cine for kids as young as 12

A few weeks af­ter snag­ging an emer­gency use au­tho­riza­tion for their mon­o­clon­al an­ti­body sotro­vimab based on in­ter­im da­ta, GSK and Vir Biotech­nol­o­gy are back with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.